|
1
|
Shaib T and El-Serag HB: The epidemiology
of cholangiocarcinoma. Semin Liver Dis. 24:115–125. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bragazzi MC, Cardinale V, Carpino G,
Venere R, Semeraro R, Gentile R, Gaudio E and Alvaro D:
Cholangiocarcinoma: Epidemiology and risk factors. Tranls
Gastrointest Cancer. 1:21–32. 2012.
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
NCCN guideline version 2018, Hepatobiliary
Cancers. http://www.nccn.org/professionals/physician_gls/default.aspxMarch
17–2018
|
|
5
|
Valle JW, Borbath I, Khan SA, Huguet F,
Gruenberger T and Arnold D: ESMO Guidelines Committee: Biliary
cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 27 Suppl 5:v28–v37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mattiucci GC, Autorino R, D'Agostino GR,
Deodato F, Macchia G, Perri V, Tringali A, Morganti AG, Mutignani M
and Valentini V: Chemoradiation and brachytherapy in extrahepatic
bile duct carcinoma. Crit Rev Oncol Hematol. 90:58–67. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deodato F, Clemente G, Mattiucci GC,
Macchia G, Costamagna G, Giuliante F, Smaniotto D, Luzi S,
Valentini V, Mutignani M, et al: Chemoradiation and brachytherapy
in biliary tract carcinoma: Long-term results. Int J Radiat Oncol
Biol Phys. 64:483–488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ghafoori AP, Nelson JW, Willett CG, Chino
J, Tyler DS, Hurwitz HI, Uronis HE, Morse MA, Clough RW and Czito
BG: Radiotherapy in the treatment of patients with unresectable
extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys.
81:654–659. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chopra S, Mathew AS, Engineer R and
Shrivastava SK: Positioning high-dose radiation in
multidisciplinary management of unresectable cholangiocarcinomas:
Review of current evidence. Indian J Gastroenterol. 33:401–407.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marinelli I, Guido A, Fuccio L, Farioli A,
Panni V, Giaccherini L, Arcelli A, Ercolani G, Brandi G, Cammelli
S, et al: Clinical target volume in biliary carcinoma: A systematic
review of pathological studies. Ant Res. 37:955–961. 2017.
|
|
11
|
Miyazaki M, Ohtsuka M, Miyakawa S, Nagino
M, Yamamoto M, Kokudo N, Sano K, Endo I, Unno M, Chijiiwa K, et al:
Classification of biliary tract cancers established by the Japanese
Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English
edition. J Hepatobiliary Pancreat Sci. 22:181–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wo JY, Yoon SS, Guimaraes AR, Wolfgang J,
Mamon HJ and Hong TS: Gastric lymph node contouring atlas: A tool
to aid in clinical target volume definition in 3-dimensional
treatment planning for gastric cancer. Pract Radiat Oncol.
3:e11–e19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Caravatta L, Sallustio G, Pacelli F,
Padula GD, Deodato F, Macchia G, Massaccesi M, Picardi V, Cilla S,
Marinelli A, et al: Clinical target volume delineation including
elective nodal irradiation in preoperative and definitive
radiotherapy of pancreatic cancer. Radiat Oncol. 7:862012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Taylor A, Rockall AG, Reznek RH and Powell
ME: Mapping pelvic lymph nodes: Guidelines for delineation in
intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys.
63:1604–1612. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haijun Y, Qiuji W, Zhenming F, Yong H,
Zhengkai L, Conghua X, Yunfeng Z and Yahua Z: A new approach to
delineating lymph node target volumes for post-operative
radiotherapy in gastric cancer: A phase II trial. Radiother Oncol.
116:245–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chung YE, Kim MJ, Park YN, Choi JY, Pyo
JY, Kim YC, Cho HJ, Kim KA and Choi SY: Varying appearances of
cholangiocarcinoma: Radiologic-pathologic correlation.
Radiographics. 29:683–700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bi AH, Zeng ZC, Ji Y, Zeng HY, Xu C, Tang
ZY, Fan J, Zhou J, Zeng MS and Tan YS: Impact factors for
microinvasion in intrahepatic cholangiocarcinoma: A possible system
for defining clinical target volume. Int J Radiat Oncol Biol Phys.
78:1427–1436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang YR, Lee KB, Jang JY, Lim CS, Kang
MJ, Kwon W, Jung WH and Kim SW: Analysis of microscopic tumor
spread patterns according to gross morphologies and suggestions for
optimal resection margins in bile duct cancer. J Gastrointest Surg.
18:1146–1154. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ebata T, Watanabe H, Ajioka Y, Oda K and
Nimura Y: Pathological appraisal of lines of resection for bile
duct carcinoma. Br J Surg. 89:1260–1267. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ogura Y, Tabata M, Kawarada Y and Mizumoto
R: Effect of hepatic invasion on the choice of hepatic resection
for advanced carcinoma of the gallbladder: Histologic analysis of
32 surgical cases. World J Surg. 22:262–267. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kondo S, Nimura Y, Kamiya J, Nagino M,
Kanai M, Uesaka K and Hayakawa N: Mode of tumor spread and surgical
strategy in gallbladder carcinoma. Langenbecks Arch Surg.
387:222–228. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Baisden JM, Kahaleh M, Weiss GR, Sanfey H,
Moskaluk CA, Yeaton P, de Lange EE and Rich TA: Multimodality
treatment with helical tomotherapy intensity modulated
radiotherapy, capecitabine, and photodynamic therapy is feasible
and well tolerated in patients with hilar cholangiocarcinoma.
Gastrintest cancer Res. 2:219–224. 2008.
|
|
23
|
Phelip JM, Vendrely V, Rostain F, Subtil
F, Jouve JL, Gasmi M, Michel P, Le Malicot K, Smith D, Seitz JF, et
al: Gemcitabine plus cisplatin versus chemoradiotherapy in locally
advanced biliary tract cancer: Fédération francophone de
cancérologie digestive 9902 phase II randomized study. Eur J
Cancer. 50:2975–2982. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Autorino R, Mattiucci GC, Ardito F,
Balducci M, Deodato F, Macchia G, Mantini G, Perri V, Tringali A,
Gambacorta MA, et al: Radiochemotherapy with gemcitabine in
unresectable extrahepatic cholangiocarcinoma: Long-term result of a
phase II study. Anticancer Res. 36:737–740. 2016.PubMed/NCBI
|
|
25
|
Lee KJ, Yi SW, Cha J, Seong J, Bang S,
Song SY, Kim HM and Park SW: A pilot study of concurrent
chemoradiotherapy with gemcitabine and cisplatin in patients with
locally advanced biliary tract cancer. Cancer Chemother Pharmacol.
78:841–846. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yi SW, Kang DR, Kim KS, Park MS, Seong J,
Park JY, Bang SM, Song SY, Chung JB and Park SW: Efficacy of
concurrent chemoradiotherapy with 5-fluorouracil or gemcitabine in
locally advanced biliary tract cancer. Cancer Chemother Pharmacol.
73:191–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen SC, Chen MH, Li CP, Chen MH, Chang
PM, Liu CY, Tzeng CH, Liu YM, Yen SH, Chao Y and Huang PI: External
bean radiation therapy with or without concurrent chemotherapy for
patients with unresectable locally advanced hilar
cholangiocarcinoma. Hepatogastroenterology. 62:102–107.
2015.PubMed/NCBI
|
